ClinicalTrials.Veeva

Menu

Early Identification of Clinical Deterioration Using a Wearable Monitoring Device

B

Biobeat

Status

Completed

Conditions

Hemodynamic Instability
Clinical Deterioration

Treatments

Device: non-invasive monitoring

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT04220359
Biobeat005

Details and patient eligibility

About

This study aims to provide myriad of physiological parameters in patients admitted in an internal medicine department, and which are defined as being in an increased risk of clinical deterioration within the first 72-hours after admission. The investigators will also conduct a retrospective comparison between physiological changes in patients who did deteriorate to those who did not. This will form the basis for the development of an algorithm for early prediction and warning of physiological and clinical deterioration during the first 72-hours of admission.

Enrollment

410 patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Males and females 18 years old and above admitted to the internal medicine department
  • On admission, the primary investigator assess their risk to deteriorate during the first 72 hours after admission as reasonably high
  • The patient is assigned to a "monitoring bed" within the department
  • The patient has signed an informed consent form

Exclusion criteria

  • Lack of informed consent
  • It is known in advance that the patient cannot take part in the study for a 72-hours period (e.g. a patient that will be taken to surgery within the next 24 hours)
  • Technical inability to attach the Biobeat patch (BB-613PW) to the patients chest

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems